1. Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma. Issue 1 (January 2023) Authors: Mo, Dun-Chang; Huang, Jian-Feng; Luo, Peng-Hui; Chen, Long; Huang, Shang-Xiao Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials. Issue 38 (23rd September 2022) Authors: Mo, Dun-Chang; Huang, Jian-Feng; Luo, Peng-Hui; Huang, Shang-Xiao; Wang, Han-Lei Journal: Medicine Issue: Volume 101:Issue 38(2022) Page Start: e30830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer. Issue 9 (20th January 2023) Authors: Mo, Dun-Chang; Huang, Jian-Feng; Luo, Peng-Hui Journal: Journal of clinical oncology Issue: Volume 41:Issue 9(2023) Page Start: 1790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer. Issue 34 (1st December 2021) Authors: Mo, Dun-Chang; Qin, Lang; Ye, Lin-Jing Journal: Journal of clinical oncology Issue: Volume 39:Issue 34(2021) Page Start: 3883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neratinib Plus Capecibine in Patients With HER2-Positive Metastatic Breast Cancer. Issue 3 (20th January 2021) Authors: Mo, Dun-Chang; Luo, Peng-Hui; Huang, Jian-Feng; Huang, Shang-Xiao; Wang, Han-Lei Journal: Journal of clinical oncology Issue: Volume 39:Issue 3(2021) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer. Issue 5 (10th February 2022) Authors: Mo, Dun-Chang; Ren, Tao Journal: Journal of clinical oncology Issue: Volume 40:Issue 5(2022) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Regarding the Children's Oncology Group ARAR0332 Protocol for Pediatric Adrenocortical Carcinoma. Issue 27 (20th September 2021) Authors: Wang, Ji-Gan; Mo, Dun-Chang Journal: Journal of clinical oncology Issue: Volume 39:Issue 27(2021) Page Start: 3087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis. Issue 11 (March 2019) Authors: Kuang, Xue-Jun; Mo, Dun-Chang; Qin, Yan; Ahir, Bhavesh K.; Wang, Jian-Jun; Peng, Zhao; Deng, Zu-Liang Other Names: Tarantino. Giovanni section editor. Journal: Medicine Issue: Volume 98:Issue 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy. Issue 8 (February 2019) Authors: Wang, Hong-Liang; Mo, Dun-Chang; Zhong, Jian-Hong; Ma, Liang; Wu, Fei-Xiang; Xiang, Bang-De; Li, Le-Qun Other Names: Iacono. Calogero section editor. Journal: Medicine Issue: Volume 98:Issue 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The angiotensin receptor and neprilysin inhibitor, LCZ696, in heart failure: A meta-analysis of randomized controlled trials. Issue 41 (14th October 2022) Authors: Chen, Yan; He, Qian; Mo, Dun-Chang; Chen, Long; Lu, Jia-Lu; Li, Rui-Xing; Huang, Jie Journal: Medicine Issue: Volume 101:Issue 41(2022) Page Start: e30904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗